- Home
- STEL vs OPK Comparison
STEL vs OPK Comparison
Compare STEL & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEL
- OPK
- Stock Information
- Founded
- STEL 2007
- OPK 2007
- Country
- STEL United States
- OPK United States
- Employees
- STEL N/A
- OPK N/A
- Industry
- STEL Major Banks
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- STEL Finance
- OPK Health Care
- Exchange
- STEL Nasdaq
- OPK Nasdaq
- Market Cap
- STEL 1.5B
- OPK 1.3B
- IPO Year
- STEL N/A
- OPK 1995
- Fundamental
- Price
- STEL $27.70
- OPK $1.66
- Analyst Decision
- STEL Hold
- OPK Strong Buy
- Analyst Count
- STEL 3
- OPK 3
- Target Price
- STEL $29.67
- OPK $2.75
- AVG Volume (30 Days)
- STEL 249.5K
- OPK 4.1M
- Earning Date
- STEL 04-25-2025
- OPK 05-06-2025
- Dividend Yield
- STEL 2.03%
- OPK N/A
- EPS Growth
- STEL N/A
- OPK N/A
- EPS
- STEL 2.15
- OPK N/A
- Revenue
- STEL $433,918,000.00
- OPK $713,142,000.00
- Revenue This Year
- STEL $2.12
- OPK N/A
- Revenue Next Year
- STEL $4.61
- OPK $6.25
- P/E Ratio
- STEL $12.87
- OPK N/A
- Revenue Growth
- STEL N/A
- OPK N/A
- 52 Week Low
- STEL $21.27
- OPK $1.15
- 52 Week High
- STEL $32.36
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- STEL 48.01
- OPK 40.64
- Support Level
- STEL $27.22
- OPK $1.75
- Resistance Level
- STEL $28.15
- OPK $1.80
- Average True Range (ATR)
- STEL 0.53
- OPK 0.06
- MACD
- STEL 0.07
- OPK -0.03
- Stochastic Oscillator
- STEL 60.53
- OPK 8.70
About STEL Stellar Bancorp Inc.
Stellar Bancorp Inc is a U.S. based bank holding company. It mainly focuses on providing commercial banking solutions to local small and mid-sized businesses and professionals. The services provided by the company include business and personal deposits account, personal and business lending, mobile and online banking, merchant banking, and others. The company more than 50 full service banking centers.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.